首页|维生素D联合胸腺肽辅助治疗急性加重期COPD患者的临床研究

维生素D联合胸腺肽辅助治疗急性加重期COPD患者的临床研究

扫码查看
目的 探讨维生素D联合胸腺肽辅助治疗急性加重期慢性阻塞性肺疾病(COPD)患者的临床效果.方法 80例急性加重期COPD患者随机分为两组.在常规治疗基础上,对照组给予胸腺肽辅助治疗,观察组给予维生素D联合胸腺肽辅助治疗.比较两组的治疗效果、动脉血气指标及血清炎性因子.结果 观察组的治疗总有效率为97.50%,明显高于对照组的85.00%(P<0.05).治疗后,观察组的PaO2水平明显高于对照组,PaCO2、IL-6、TNF-α水平均明显低于对照组(P<0.05).结论 维生素D联合胸腺肽辅助治疗急性加重期COPD效果显著,可明显改善患者的动脉血气指标,减轻患者的炎性反应.
Clinical Study of Vitamin D Combined with Thymosin in the Adjuvant Treatment of Patients with Acute Exacerbation of COPD
Objective To explore the clinical effect of vitamin D combined with thymosin in the adjuvant treatment of patients with acute exacerbation of chronic obstructive pulmonary disease(COPD).Methods 80 patients with acute exacerbation of COPD were randomly divided into two groups.On the basis of conventional treatment,the control group was given thymosin adjuvant therapy,and the observation group was given vitamin D combined with thymosin adjuvant therapy.The therapeutic effect,arterial blood gas indicators and serum inflammatory factors were compared between the two groups.Results The total effective rate of treatment in the observation group was 97.50%,significantly higher than 85.00%in the control group(P<0.05).After treatment,the level of PaO2 in the observation group was significantly higher than that in the control group,and the levels of PaCO2,IL-6 and TNF-α were significantly lower than those in the control group(P<0.05).Conclusions Vitamin D combined with thymosin in the adjuvant treatment of acute exacerbation of COPD has significant effect,which can obviously improve the arterial blood gas indicators and relieve the inflammatory response of patients.

Chronic obstructive pulmonary diseaseThymosinVitamin DArterial blood gas indicatorInflammatory factor

尹士营、贾祖强

展开 >

濮阳惠民医院呼吸内科,河南濮阳 457000

慢性阻塞性肺疾病 胸腺肽 维生素D 动脉血气指标 炎性因子

2024

临床医学工程
国家医疗保健器具工程技术研究中心

临床医学工程

影响因子:0.193
ISSN:1674-4659
年,卷(期):2024.31(6)
  • 6